Lorenzo Bosisio

Chief Executive Officer


Lorenzo Bosisio, CEO at EffRx Pharmaceuticals, has a track record of more than 20 years of international Marketing, Business Development and Sales across competitive markets within both blue-chip and start-up companies.

Most recently Mr. Bosisio served as Chief Commercial Officer for Tissot Medical Research and as EMEA Marketing Director for Alexion. While serving at Amgen International for 9 years, he built from scratch the commercial infrastructure for the flagship drug denosumab, launched Prolia®, optimized Aranesp® and launched Mimpara®. At PricewaterhouseCoopers Switzerland he led Marketing and Business Development for its major practice. Earlier in his career he set up the commercial organization and led Marketing & Sales for a start-up.

Mr. Bosisio holds a BSc in Economics & Business Administration and has earned an MBA from HEC School of Management Paris. Mr. Bosisio has worked and studied in Switzerland, US, France, Italy, UK and Australia and speaks English, German, French, Italian, and Spanish.